Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28276 - 28300 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	ALPK2	115701	downregulated	Cytarabine results in decreased expression of ALPK2 mRNA	18q21.31-q21.32	A21886
Cytarabine	Approved Investigational	ANGPTL2	23452	downregulated	Cytarabine results in decreased expression of ANGPTL2 mRNA	9q33.3	A21886
Cytarabine	Approved Investigational	ANKRD36C	400986	upregulated	Cytarabine results in increased expression of ANKRD36C mRNA	2q11.1	A21886
Cytarabine	Approved Investigational	ANKS1A	23294	downregulated	Cytarabine results in decreased expression of ANKS1A mRNA	6p21.31	A21886
Cytarabine	Approved Investigational	ANO8	57719	upregulated	Cytarabine results in increased expression of ANO8 mRNA	19p13.11	A21886
Cytarabine	Approved Investigational	ANXA2	302	downregulated	Cytarabine results in decreased expression of ANXA2 mRNA	15q22.2	A21886
Cytarabine	Approved Investigational	ANXA2	302	upregulated	Cytarabine results in increased expression of ANXA2 mRNA	15q22.2	A20721
Cytarabine	Approved Investigational	ANXA6	309	downregulated	Cytarabine results in decreased expression of ANXA6 mRNA	5q33.1	A21886
Cytarabine	Approved Investigational	ANXA8	653145	downregulated	Cytarabine results in decreased expression of ANXA8 mRNA	10q11.22	A21886
Cytarabine	Approved Investigational	ANXA8L1	728113	downregulated	Cytarabine results in decreased expression of ANXA8L1 mRNA	10q11.22	A21886
Cytarabine	Approved Investigational	APLNR	187	downregulated	Cytarabine results in decreased expression of APLNR mRNA	11q12.1	A21886
Cytarabine	Approved Investigational	APOBEC3B	9582	upregulated	Cytarabine results in increased expression of APOBEC3B mRNA	22q13.1	A20985
Cytarabine	Approved Investigational	AQP1	358	downregulated	Cytarabine results in decreased expression of AQP1 mRNA	7p14.3	A21886
Cytarabine	Approved Investigational	ARG2	384	downregulated	Cytarabine results in decreased expression of ARG2 mRNA	14q24.1	A21886
Cytarabine	Approved Investigational	ARHGAP44	9912	downregulated	Cytarabine results in decreased expression of ARHGAP44 mRNA	17p12	A21886
Cytarabine	Approved Investigational	ARHGDIB	397	downregulated	Cytarabine results in decreased expression of ARHGDIB mRNA	12p12.3	A21886
Cytarabine	Approved Investigational	ARHGEF3	50650	downregulated	Cytarabine results in decreased expression of ARHGEF3 mRNA	3p14.3	A21886
Cytarabine	Approved Investigational	ART4	420	downregulated	Cytarabine results in decreased expression of ART4 mRNA	12p12.3	A21886
Cytarabine	Approved Investigational	ART5	116969	downregulated	Cytarabine results in decreased expression of ART5 mRNA	11p15.4	A21886
Cytarabine	Approved Investigational	ATF3	467	downregulated	Cytarabine results in decreased expression of ATF3 mRNA	1q32.3	A21886
Cytarabine	Approved Investigational	ATL1	51062	upregulated	Cytarabine results in increased expression of ATL1 mRNA	14q22.1	A21886
Cytarabine	Approved Investigational	ATN1	1822	upregulated	Cytarabine results in increased expression of ATN1 mRNA	12p13.31	A21886
Cytarabine	Approved Investigational	ATP10D	57205	upregulated	Cytarabine results in increased expression of ATP10D mRNA	4p12	A20985
Cytarabine	Approved Investigational	ATP1B1	481	downregulated	Cytarabine results in decreased expression of ATP1B1 mRNA	1q24.2	A21886
Cytarabine	Approved Investigational	ATP7B	540	downregulated	Cytarabine results in decreased expression of ATP7B mRNA	13q14.3	A21886

Displaying entries 28276 - 28300 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability